These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11222431)

  • 21. Thiazolidinediones--a means to endpoint intervention.
    Jerkins TW
    Tenn Med; 2000 Nov; 93(11):403-5. PubMed ID: 11077884
    [No Abstract]   [Full Text] [Related]  

  • 22. Beneficial hepatic effect of troglitazone in a patient with antimitochondrial antibody-negative primary biliary cirrhosis.
    Okai T; Mouri H; Yamaguchi Y; Nakanuma Y; Sawabu N
    Am J Gastroenterol; 2002 Jan; 97(1):209-10. PubMed ID: 11808957
    [No Abstract]   [Full Text] [Related]  

  • 23. Rosiglitazone monotherapy and type 2 diabetes.
    Lawrence IG
    Diabet Med; 2001 Nov; 18 Suppl 4():6-8. PubMed ID: 11989215
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticipated US approval for rosiglitazone and pioglitazone.
    Diabetes Obes Metab; 1999 May; 1(3):181-2. PubMed ID: 11220298
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetes. Type-righting lessons.
    Bryan J
    Health Serv J; 2000 Nov; 110(5733):suppl 11-2. PubMed ID: 11138528
    [No Abstract]   [Full Text] [Related]  

  • 26. Pioglitazone and rosiglitazone for diabetes.
    Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The thiazolidinediones or "glitazones" a treatment option for type 2 diabetes mellitus.
    Brown MN
    Med Health R I; 2000 Apr; 83(4):118-20. PubMed ID: 10821014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efffect of addition of low-dose rosiglitazone to sulphonylurea therapy on glycemic control in type 2 diabetic patients.
    Yang J; Di F; He R; Zhu X; Wang D; Yang M; Wang Y; Yuan S; Chen J
    Chin Med J (Engl); 2003 May; 116(5):785-7. PubMed ID: 12875702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosiglitazone--useful drug but has side effects.
    Vidhya S; Mohan V
    J Assoc Physicians India; 2002 Apr; 50():615. PubMed ID: 12164432
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rosiglitazone: clinical data].
    Blickle JF
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
    [No Abstract]   [Full Text] [Related]  

  • 31. [Type 2 diabetes--new treatment].
    Lervang HH
    Ugeskr Laeger; 2001 Oct; 163(44):6101. PubMed ID: 11715150
    [No Abstract]   [Full Text] [Related]  

  • 32. Accelerated hypertension due to rosiglitazone therapy.
    Vikram NK; Misra A; Devi JR
    Indian Heart J; 2002; 54(6):733. PubMed ID: 12674195
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral antidiabetic agents safe with renal disease?
    Bakris G
    Postgrad Med; 2000 Jun; 107(7):66. PubMed ID: 10887446
    [No Abstract]   [Full Text] [Related]  

  • 34. Rosiglitazone.
    Goldstein BJ
    Int J Clin Pract; 2000 Jun; 54(5):333-7. PubMed ID: 10954962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The debate on glitazones].
    Lindberg M
    Ugeskr Laeger; 2002 Feb; 164(9):1233-4. PubMed ID: 11899518
    [No Abstract]   [Full Text] [Related]  

  • 36. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
    Consoli A; Formoso G
    Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new rosiglitazone story: its place today in type 2 diabetes management.
    Ambery P; Pandya B
    Prim Care Diabetes; 2009 Feb; 3(1):57-9. PubMed ID: 19269912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 39. [Primary prevention of diabetes mellitus by pharmacological intervention].
    Noda M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of diabetes during Ramadan.
    Whitelaw D
    Diabet Med; 2005 Sep; 22 Suppl 4():21-3. PubMed ID: 16109015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.